Merck’s experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of coronavirus, including the predominant and highly contagious delta, laboratory studies The company said on
Most side effects after a third dose of a Covid vaccine are mild or moderate, and occur at about as often as after shot two, a US study showed Tuesday
The World Health Organization (WHO) on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. Persons with non-severe Covid-19 who are nonetheless
Strict tobacco control is needed to protect public health and to achieve a tobacco-free Bangladesh by 2040, announced by the Prime Minister Sheikh Hasina, said experts. Therefore, it is necessary
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek US authorization for this age group soon — a key step toward beginning
Researchers are collecting samples from bats in northern Cambodia in a bid to understand the coronavirus pandemic, returning to a region where a very similar virus was found in the
Ebola has been defeated. Vaccines and medical treatments have brought the deadly and terrifying disease under control, says Jean-Jacques Muyembe, the Congolese professor who first discovered the virus more than
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. The findings of the
The vaccines are still providing strong protection, a year on from the initial two doses, says the scientist who developed the Oxford-AZ vaccine. The UK’s vaccine advisory body is set
These aren’t the only instances of people having encountered heart attacks post-COVID. An Oxford-led study conducted recently established that over 50%, or 5 out of every 10 COVID-19 patients with